| BSE: 524506 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE683E01017 |
| BSE 00:00 | 18 Apr | 359.70 |
-12.40 (-3.33%) |
OPEN
381.10 |
HIGH
381.10 |
LOW
306.00 |
| NSE 05:30 | 01 Jan | Coral Laboratories Ltd |
| OPEN | 381.10 |
| PREVIOUS CLOSE | 372.10 |
| VOLUME | 2420 |
| 52-Week high | 648.00 |
| 52-Week low | 295.20 |
| P/E | 8.93 |
| Mkt Cap.(Rs cr) | 128 |
| Buy Price | 348.55 |
| Buy Qty | 1.00 |
| Sell Price | 359.70 |
| Sell Qty | 259.00 |
Coral Laboratories Limited has been promoted by Navin B Doshi of the DWD group. The Company is spearheaded by Kishor R Mehta as Executive Director. CLL produces various pharmaceutical formulations. To Manufacture pharmaceutical formulations like tablets,capsules the company went into public issue in March 94 at a total cost of Rs.2.5 crores. The project has been completed successfully CLL ...> More
| COMPANY INFORMATION | |||||||
| Independent Director : | Sheela R Kamdar | ||||||
| Whole-time Director : | Girish Dhameja | ||||||
| Independent Director : | Sanket Mehta | ||||||
| Director & CFO : | Sushma Chinchane | ||||||
| Company Secretary : | Nirali Mehta | ||||||
| AUDITOR : | SPVM & Co | ||||||
| IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
| HOUSE NAME : | Coral | ||||||
| Registered office | |||||||
| SF-206 Silver Oak Complex, BPC Road,Vadodara,Gujarat-390020 | |||||||
| Ph : 91-022-2500 5245/46 | |||||||
| WEBSITE : http://www.corallab.com | |||||||
| E-mail : cs@corallab.com | |||||||
